Logo
x

Search

Subscribe Now

 Pharma

Mosaic Therapeutics In-Licenses ASTX029 & ASTX295 from Astex Pharmaceuticals for Combination Therapy Development for Oncology

Mosaic Therapeutics In-Licenses ASTX029 & ASTX295 from Astex Pharmaceuticals for Combination Therapy Development for Oncology

  • April 24, 2025
Repertoire Immune Medicines Collaborates with Genentech to Develop T cell-Targeted Therapies for an Autoimmune Disease

Repertoire Immune Medicines Collaborates with Genentech to Develop T cell-Targeted Therapies for an Autoimmune Disease

  • April 24, 2025
Boehringer Ingelheim Enters a ~$573M Deal with Tessellate Bio to Develop Novel Therapies for ALT-positive tumors

Boehringer Ingelheim Enters a ~$573M Deal with Tessellate Bio to Develop Novel Therapies for ALT-positive tumors

  • April 23, 2025
Regeneron Enters a ~$3B Multi-Year Manufacturing Agreement with FUJIFILM Diosynth Biotechnologies

Regeneron Enters a ~$3B Multi-Year Manufacturing Agreement with FUJIFILM Diosynth Biotechnologies

  • April 23, 2025
GC Cell Partners with DAAN Biotherapeutics for Tumor Antigen-Specific Antibody Sequence

GC Cell Partners with DAAN Biotherapeutics for Tumor Antigen-Specific Antibody Sequence

  • April 21, 2025
Ollin Biosciences Signs a ~$440M Licensing Agreement with VelaVigo Bio for VBS-102

Ollin Biosciences Signs a ~$440M Licensing Agreement with VelaVigo Bio for VBS-102

  • April 21, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.